Fleury has loss of r $ 800 thousand in 4th tri of 2013

SAO PAULO-the Fleury diagnostic medicine group reported net loss of R $ 800 thousand in the fourth quarter of 2013, reversing a net profit of r $ 16.5 million in the same period of the previous year. In the last year-to-date, net income reached r $ 61,1 million, retraction of 42.6% before 2012.
The Ebitda (earnings before interest, taxes, depreciation and amortization) of the company in the last three months of the year amounted to r $ 45.2 million, 38.7% drop compared to the previous year. In twelve months, Ebitda reached r $ 277,9 million, 11.7% reduction.
The company's net revenue between October and December was r $ 389,9 million, 3.7 percent higher than the same period in 2012. From January to December, revenue stood at $ 1,656 billion, an increase of 10.3%.